GlobalData on MSN

Silver Creek’s stroke hopeful yields mixed results in Phase II trial

If approved, the targeted IGF-1 fusion protein would become the only treatment available for late-window stroke patients ...

Silver Creek Pharmaceuticals Announces Positive Phase 2 Results for Scp776 in Acute Ischemic Stroke

Key Highlights Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up ...
The Malaysian Reserve

Basking Biosciences Doses First Patients in Part B of Phase 2 Stroke Trial, Unlocks $27.5 Million Financing Tranche, and Appoints Julia C. Owens, Ph.D. as Chief Executi…

Financing supports execution of Phase 2b RAISE trial evaluating BB-031, an investigational reversible thrombolytic for acute ...
MedPage Today

Alteplase Also Shows Its Mettle for Late Strokes in HOPE Trial

LOS ANGELES -- The HOPE trial made another case for extending the therapeutic window for IV thrombolysis in acute ischemic stroke, potentially widening the pool of people eligible for therapy. Among ...
Healthline

How Does Eating (or Not Eating) Affect Your Blood Pressure?

Eating can cause blood pressure to decrease temporarily as the body directs blood flow to the digestive system; this is more likely to affect older adults. Fasting may lower blood pressure, but it ...